This marks the second FDA-cleared ECG-AI device in Tempus’ cardiovascular product suite, following its previously cleared Tempus ECG-AF solution. The new software analyzes resting, non-ambulatory ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

Detectives in Olomouc have used AI to create a probable image of the murderer of a video-rental employee in 2005. From the original facial composite, they have created a probable image of the ...

Tempus AITEM reached an important technical milestone, with its Relative Strength (RS) Rating moving into the 90-plus ...

Tempus AI TEM expects full-year 2025 revenues of $1.25 billion (up from the previous $1.24 billion guidance), which represents approximately 80% annual growth. The company also expects adjusted EBITDA ...

Tempus AI (NASDAQ:TEM) provides advanced healthcare technology solutions, including molecular diagnostics, data analytics ...

Recognizing that breast cancer guidelines, much like those for lung cancer, are constantly evolving, Tempus is working to ...

ARKK surged in 2Q25 on AI and crypto bets like Circle and Tempus, with strong returns despite outflows and high sector risk.

One of Wood's favorite AI stocks has been criticized by CNBC host Jim Cramer multiple times in 2025, including this week.

Apple's $60 billion cash pile and a rare executive shake-up reignite speculation: will the tech giant finally go on an AI ...

ClaimsFiler, a FREE shareholder information service, reminds investors that they have until August 12, 2025 to file lead plaintiff applications in a ...

Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at ...